Male Hypogonadism Market Report by Therapy Type (Testosterone Replacement Therapy, Gonadotropin-Releasing Hormones Therapy), Drug Delivery (Topical Gels, Injectables, Transdermal Patches, and Others), Application (Kallmann Syndrome, Klinefelters Syndrome, Pituitary Disorders, and Others), and Region 2024-2032
The global male hypogonadism market size reached US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.54% during 2024-2032. A considerable rise in the prevalence of testosterone deficiency in males, the rising awareness of male hypogonadism treatment choices among the patient population, and increasing health consciousness represent some of the key factors driving the market.
Male hypogonadism is a medical condition in which the testes fail to produce enough testosterone, leading to a lack of muscle growth, impaired hair growth, breast development, as well as a lack of deepening of the voice. The medical condition is characterized by a lack of testosterone or spermatozoa production in men. It is caused owing to the disorder related to the testes (primary hypogonadism) or the hypothalamic-pituitary axis (secondary hypogonadism). An individual with hypogonadism may suffer from a variety of organ dysfunctions as well as a reduction in quality of life since it originates from a testicular problem or disorder that affects the hypothalamus and pituitary gland. Hypogonadism in men can be genetic or acquired, caused by hormonal imbalances, medications or aging. Several congenital enzyme abnormalities are responsible for causing different degrees of androgen resistance throughout the body. Hypogonadism is most common in men over the age of 60, and the symptoms and indications of the deficiency vary accordingly.
Male Hypogonadism Market Trends:
The global market is primarily driven by a considerable rise in the prevalence of testosterone deficiency in males, along with the growing infertility rates. This can be attributed to the increasing incidences of chronic lifestyle disorders, including obesity and diabetes. In line with this, the expanding geriatric population that is more susceptible to developing male hypogonadism is also providing an impetus to the market. Moreover, the rising awareness of male hypogonadism treatment choices among the patient population is also acting as a significant growth-inducing factor. Government bodies across several countries are promoting awareness of hypogonadism treatment methods, including testosterone replacement therapy (TST). However, severe adverse reactions associated with external testosterone hormone injections are acting as a significant growth-restraining factor for the male hypogonadism market. Conversely, the increasing number of clinical trials and the emergence of new treatment options are expected to create new male hypogonadism market opportunities for growth during the forecast period. Apart from this, continual technological advancements in the development of medical infrastructure on the global level are creating a positive outlook for the market. Some of the other factors contributing to the market include rapid urbanization, increasing health consciousness, high medical expenditure and extensive research and development (R&D) activities.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global male hypogonadism market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on therapy type, drug delivery and application.
Therapy Type Insights
Testosterone Replacement Therapy
Gonadotropin-Releasing Hormones Therapy
The report has provided a detailed breakup and analysis of the male hypogonadism market based on the therapy type. This includes testosterone replacement therapy and gonadotropin-releasing hormones therapy. According to the report, testosterone replacement therapy represented the largest segment.
Drug Delivery Insights
Topical Gels
Injectables
Transdermal Patches
Others
The report has provided a detailed breakup and analysis of the male hypogonadism market based on the drug delivery. This includes topical gels, injectables, transdermal patches, and others. According to the report, topical gels represented the largest segment.
Application Insights
Kallmann Syndrome
Klinefelters Syndrome
Pituitary Disorders
Others
A detailed breakup and analysis of the male hypogonadism market based on the application has also been provided in the report. This includes Kallmann Syndrome, Klinefelters Syndrome, pituitary disorders, and others.
Regional Insights
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for male hypogonadism. Some of the factors driving the North America male hypogonadism market include the growing geriatric population, rising prevalence of sedentary lifestyle and related medical conditions, increasing number of clinical trials, the emergence of new treatment options, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global male hypogonadism market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AbbVie Inc, Endo International Plc, Ferring Holding S.A, Grьnenthal GmbH, Lilly USA, LLC (Eli Lilly and Company), Pfizer Inc, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd, etc.
Key Questions Answered in This Report:
How has the global male hypogonadism market performed so far and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global male hypogonadism market?
What are the key regional markets?
Which countries represent the most attractive male hypogonadism markets?
What is the breakup of the market based on the therapy type?
What is the breakup of the market based on the drug delivery?
What is the breakup of the market based on the application?
What is the competitive structure of the global male hypogonadism market?
Who are the key players/companies in the global male hypogonadism market?
Male hypogonadism is a medical condition in which the testes fail to produce enough testosterone, leading to a lack of muscle growth, impaired hair growth, breast development, as well as a lack of deepening of the voice. The medical condition is characterized by a lack of testosterone or spermatozoa production in men. It is caused owing to the disorder related to the testes (primary hypogonadism) or the hypothalamic-pituitary axis (secondary hypogonadism). An individual with hypogonadism may suffer from a variety of organ dysfunctions as well as a reduction in quality of life since it originates from a testicular problem or disorder that affects the hypothalamus and pituitary gland. Hypogonadism in men can be genetic or acquired, caused by hormonal imbalances, medications or aging. Several congenital enzyme abnormalities are responsible for causing different degrees of androgen resistance throughout the body. Hypogonadism is most common in men over the age of 60, and the symptoms and indications of the deficiency vary accordingly.
Male Hypogonadism Market Trends:
The global market is primarily driven by a considerable rise in the prevalence of testosterone deficiency in males, along with the growing infertility rates. This can be attributed to the increasing incidences of chronic lifestyle disorders, including obesity and diabetes. In line with this, the expanding geriatric population that is more susceptible to developing male hypogonadism is also providing an impetus to the market. Moreover, the rising awareness of male hypogonadism treatment choices among the patient population is also acting as a significant growth-inducing factor. Government bodies across several countries are promoting awareness of hypogonadism treatment methods, including testosterone replacement therapy (TST). However, severe adverse reactions associated with external testosterone hormone injections are acting as a significant growth-restraining factor for the male hypogonadism market. Conversely, the increasing number of clinical trials and the emergence of new treatment options are expected to create new male hypogonadism market opportunities for growth during the forecast period. Apart from this, continual technological advancements in the development of medical infrastructure on the global level are creating a positive outlook for the market. Some of the other factors contributing to the market include rapid urbanization, increasing health consciousness, high medical expenditure and extensive research and development (R&D) activities.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global male hypogonadism market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on therapy type, drug delivery and application.
Therapy Type Insights
Testosterone Replacement Therapy
Gonadotropin-Releasing Hormones Therapy
The report has provided a detailed breakup and analysis of the male hypogonadism market based on the therapy type. This includes testosterone replacement therapy and gonadotropin-releasing hormones therapy. According to the report, testosterone replacement therapy represented the largest segment.
Drug Delivery Insights
Topical Gels
Injectables
Transdermal Patches
Others
The report has provided a detailed breakup and analysis of the male hypogonadism market based on the drug delivery. This includes topical gels, injectables, transdermal patches, and others. According to the report, topical gels represented the largest segment.
Application Insights
Kallmann Syndrome
Klinefelters Syndrome
Pituitary Disorders
Others
A detailed breakup and analysis of the male hypogonadism market based on the application has also been provided in the report. This includes Kallmann Syndrome, Klinefelters Syndrome, pituitary disorders, and others.
Regional Insights
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for male hypogonadism. Some of the factors driving the North America male hypogonadism market include the growing geriatric population, rising prevalence of sedentary lifestyle and related medical conditions, increasing number of clinical trials, the emergence of new treatment options, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global male hypogonadism market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AbbVie Inc, Endo International Plc, Ferring Holding S.A, Grьnenthal GmbH, Lilly USA, LLC (Eli Lilly and Company), Pfizer Inc, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd, etc.
Key Questions Answered in This Report:
How has the global male hypogonadism market performed so far and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global male hypogonadism market?
What are the key regional markets?
Which countries represent the most attractive male hypogonadism markets?
What is the breakup of the market based on the therapy type?
What is the breakup of the market based on the drug delivery?
What is the breakup of the market based on the application?
What is the competitive structure of the global male hypogonadism market?
Who are the key players/companies in the global male hypogonadism market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL MALE HYPOGONADISM MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY THERAPY TYPE
6.1 Testosterone Replacement Therapy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Gonadotropin-Releasing Hormones Therapy
6.2.1 Market Trends
6.2.3 Market Forecast
7 MARKET BREAKUP BY DRUG DELIVERY
7.1 Topical Gels
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Injectables
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Transdermal Patches
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Kallmann Syndrome
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Klinefelters Syndrome
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Pituitary Disorders
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 DRIVERS, RESTRAINTS, AND OPPORTUNITIES
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AbbVie Inc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Endo International Plc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Ferring Holding S.A
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Grьnenthal GmbH
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Lilly USA, LLC (Eli Lilly and Company)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Pfizer Inc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Sun Pharmaceutical Industries Limited
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Teva Pharmaceutical Industries Ltd
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL MALE HYPOGONADISM MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY THERAPY TYPE
6.1 Testosterone Replacement Therapy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Gonadotropin-Releasing Hormones Therapy
6.2.1 Market Trends
6.2.3 Market Forecast
7 MARKET BREAKUP BY DRUG DELIVERY
7.1 Topical Gels
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Injectables
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Transdermal Patches
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Kallmann Syndrome
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Klinefelters Syndrome
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Pituitary Disorders
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 DRIVERS, RESTRAINTS, AND OPPORTUNITIES
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AbbVie Inc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Endo International Plc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Ferring Holding S.A
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Grьnenthal GmbH
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Lilly USA, LLC (Eli Lilly and Company)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Pfizer Inc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Sun Pharmaceutical Industries Limited
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Teva Pharmaceutical Industries Ltd
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
LIST OF TABLES
Table 1: Global: Male Hypogonadism Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Male Hypogonadism Market Forecast: Breakup by Therapy Type (in Million US$), 2024-2032
Table 3: Global: Male Hypogonadism Market Forecast: Breakup by Drug Delivery (in Million US$), 2024-2032
Table 4: Global: Male Hypogonadism Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Male Hypogonadism Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Male Hypogonadism Market: Competitive Structure
Table 7: Global: Male Hypogonadism Market: Key Players
Table 1: Global: Male Hypogonadism Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Male Hypogonadism Market Forecast: Breakup by Therapy Type (in Million US$), 2024-2032
Table 3: Global: Male Hypogonadism Market Forecast: Breakup by Drug Delivery (in Million US$), 2024-2032
Table 4: Global: Male Hypogonadism Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Male Hypogonadism Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Male Hypogonadism Market: Competitive Structure
Table 7: Global: Male Hypogonadism Market: Key Players
LIST OF FIGURES
Figure 1: Global: Male Hypogonadism Market: Major Drivers and Challenges
Figure 2: Global: Male Hypogonadism Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Male Hypogonadism Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Male Hypogonadism Market: Breakup by Therapy Type (in %), 2023
Figure 5: Global: Male Hypogonadism Market: Breakup by Drug Delivery (in %), 2023
Figure 6: Global: Male Hypogonadism Market: Breakup by Application (in %), 2023
Figure 7: Global: Male Hypogonadism Market: Breakup by Region (in %), 2023
Figure 8: Global: Male Hypogonadism (Testosterone Replacement Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Male Hypogonadism (Testosterone Replacement Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Male Hypogonadism (Gonadotropin-Releasing Hormones Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Male Hypogonadism (Gonadotropin-Releasing Hormones Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Male Hypogonadism (Topical Gels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Male Hypogonadism (Topical Gels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Male Hypogonadism (Injectables) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Male Hypogonadism (Injectables) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Male Hypogonadism (Transdermal Patches) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Male Hypogonadism (Transdermal Patches) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Male Hypogonadism (Other Drug Deliveries) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Male Hypogonadism (Other Drug Deliveries) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Male Hypogonadism (Kallmann Syndrome) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Male Hypogonadism (Kallmann Syndrome) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Male Hypogonadism (Klinefelters Syndrome) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Male Hypogonadism (Klinefelters Syndrome) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Male Hypogonadism (Pituitary Disorders) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Male Hypogonadism (Pituitary Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Male Hypogonadism (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Male Hypogonadism (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: North America: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: North America: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: United States: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: United States: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Canada: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Canada: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Asia-Pacific: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Asia-Pacific: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: China: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: China: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Japan: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Japan: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: India: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: India: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: South Korea: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: South Korea: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Australia: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Australia: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Indonesia: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Indonesia: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Others: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Others: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Europe: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Europe: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Germany: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Germany: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: France: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: France: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: United Kingdom: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: United Kingdom: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Italy: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Italy: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Spain: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Spain: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Russia: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Russia: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Others: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Others: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Latin America: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Latin America: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Brazil: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Brazil: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Mexico: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Mexico: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Others: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Others: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Middle East and Africa: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Middle East and Africa: Male Hypogonadism Market: Breakup by Country (in %), 2023
Figure 76: Middle East and Africa: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Global: Male Hypogonadism Industry: Drivers, Restraints, and Opportunities
Figure 78: Global: Male Hypogonadism Industry: Value Chain Analysis
Figure 79: Global: Male Hypogonadism Industry: Porter's Five Forces Analysis
Figure 1: Global: Male Hypogonadism Market: Major Drivers and Challenges
Figure 2: Global: Male Hypogonadism Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Male Hypogonadism Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Male Hypogonadism Market: Breakup by Therapy Type (in %), 2023
Figure 5: Global: Male Hypogonadism Market: Breakup by Drug Delivery (in %), 2023
Figure 6: Global: Male Hypogonadism Market: Breakup by Application (in %), 2023
Figure 7: Global: Male Hypogonadism Market: Breakup by Region (in %), 2023
Figure 8: Global: Male Hypogonadism (Testosterone Replacement Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Male Hypogonadism (Testosterone Replacement Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Male Hypogonadism (Gonadotropin-Releasing Hormones Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Male Hypogonadism (Gonadotropin-Releasing Hormones Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Male Hypogonadism (Topical Gels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Male Hypogonadism (Topical Gels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Male Hypogonadism (Injectables) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Male Hypogonadism (Injectables) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Male Hypogonadism (Transdermal Patches) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Male Hypogonadism (Transdermal Patches) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Male Hypogonadism (Other Drug Deliveries) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Male Hypogonadism (Other Drug Deliveries) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Male Hypogonadism (Kallmann Syndrome) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Male Hypogonadism (Kallmann Syndrome) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Male Hypogonadism (Klinefelters Syndrome) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Male Hypogonadism (Klinefelters Syndrome) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Male Hypogonadism (Pituitary Disorders) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Male Hypogonadism (Pituitary Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Male Hypogonadism (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Male Hypogonadism (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: North America: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: North America: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: United States: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: United States: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Canada: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Canada: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Asia-Pacific: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Asia-Pacific: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: China: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: China: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Japan: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Japan: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: India: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: India: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: South Korea: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: South Korea: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Australia: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Australia: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Indonesia: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Indonesia: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Others: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Others: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Europe: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Europe: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Germany: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Germany: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: France: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: France: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: United Kingdom: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: United Kingdom: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Italy: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Italy: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Spain: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Spain: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Russia: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Russia: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Others: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Others: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Latin America: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Latin America: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Brazil: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Brazil: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Mexico: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Mexico: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Others: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Others: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Middle East and Africa: Male Hypogonadism Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Middle East and Africa: Male Hypogonadism Market: Breakup by Country (in %), 2023
Figure 76: Middle East and Africa: Male Hypogonadism Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Global: Male Hypogonadism Industry: Drivers, Restraints, and Opportunities
Figure 78: Global: Male Hypogonadism Industry: Value Chain Analysis
Figure 79: Global: Male Hypogonadism Industry: Porter's Five Forces Analysis
